Hepato-Renal Protective Potential of Dimethyl Fumarate in Alloxan-Induced Diabetic Mice Model by Modulating of Sirt1, Nrf2 and Inflammatory Genes Expressions
Preprint
- 7 August 2023
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Background: Despite advances in diabetes-related treatments, the effects of the disease have not yet been adequately reversed or prevented in patients. Therefore, there is an urgent need to develop more effective medication-assisted treatments in this field. Methods: In this study, type 1 diabetes mice models was established using multiple low-dose alloxan, and the diabetic mice were treated with three doses of dimethyl fumarate (DMF) i.e low, medium, and high viz. 20, 40 and 80 mg/kg, respectively for a period of 21 days. Then, specific test were done to evaluate blood biochemical parameters, oxidative stress markers, inflammatory genes expression, and histopathological changes in the mice kidney and liver. Results: The obtained results showed remarkably improved anti-diabetic, hepato-renal-protective, and oxidative stress indexes of DMF in alloxan-induced diabetic mice (p< 0.001). Treated mice with DMF demonstrated a noteworthy decrease in blood glucose levels when compared with diabetic group (p< 0.001). Diabetic liver and kidney tissues showed marked dilation of bile ducts, tubules, infiltration, and inflammation. On the contrary, the histological features of the treated mice with DMF improve as shown by normal size of glomerular capillaries along with decrease in less dilatation of ducts in comparison with diabetic mice. The real-time quantitative PCR results indicated that DMF injection decreased the alloxan-induced increase of significant elevations in mRNA levels of pro-inflammatory cytokines and adhesion molecules such as TNF-α, IL-6, and NF-κB levels in both kidney and liver tissues. Meanwhile, mice treated with DMF showed an increase in Sirt1 and Nrf2 expression in comparison to diabetic group. Conclusion: In conclusion, it can be concluded that DMF treatment provides hepato-renal protective effects on alloxan-induced diabetic mice model by attenuating ROS inflammatory pathways. Keywords: Diabetes, Dimethyl fumarate, Alloxan, Anti-inflammatory responses, Hepato-renal-protective effects.Keywords
All Related Versions
This publication has 22 references indexed in Scilit:
- Targeting NRF2 in Type 2 diabetes mellitus and depression: Efficacy of natural and synthetic compoundsEuropean Journal of Pharmacology, 2022
- Development of clinical prediction models for renal and cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease using time-varying predictorsJournal of Diabetes and its Complications, 2022
- Evolution of liver fibrosis and steatosis markers in patients with type 2 diabetes after metformin treatment for 2 yearsJournal of Diabetes and its Complications, 2021
- Dimethyl fumarate ameliorates diabetes-associated vascular complications through ROS-TXNIP-NLRP3 inflammasome pathwayLife Sciences, 2020
- Renoprotective potential of dimethyl fumarate in streptozotocin induced diabetic nephropathy in Wistar ratsObesity Medicine, 2020
- Antioxidant and anti-inflammatory effects of dimethyl fumarate in hypercholesterolemic rabbitsEgyptian Journal of Basic and Applied Sciences, 2017
- The study of diabetes prevalence and related risk factors in Fuyang, a Chinese county under rapid urbanizationInternational Journal of Diabetes in Developing Countries, 2015
- Effect of gold nanoparticles on glutathione and malondialdehyde levels in liver, lung and heart of ratsSaudi Journal of Biological Sciences, 2012
- SirT1 Gain of Function Increases Energy Efficiency and Prevents Diabetes in MiceCell Metabolism, 2008
- Suppression of Reactive Oxygen Species and Neurodegeneration by the PGC-1 Transcriptional CoactivatorsCell, 2006